CorPath® GRX Neuro Study

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 21, 2020

Primary Completion Date

April 23, 2022

Study Completion Date

October 12, 2022

Conditions
Intracranial AneurysmSubarachnoid HemorrhageHeadache
Interventions
DEVICE

Robotic Endovascular Procedure

After providing written informed consent, subjects with cerebral aneurysms may have their aneurysm treated using the CorPath GRX System.

Trial Locations (10)

4215

Gold Coast University Hospital, Southport

47003

University Clinical Hospital of Valladolid, Valladolid

75013

Hôpital Pitié-Salpêtrière, Paris

75940

Hôpital de la Fondation Rothschild, Paris

Unknown

Uniklinikum Salzburg, Salzburg

St. Michael's Hospital, Toronto

CHU Montpellier - Hôpital Gui de Chauliac, Montpellier

Inselspital, Universitätsspital Bern, Bern

M5T 2S8

Toronto Western Hospital, Toronto

08035

Vall d'Hebron University Hospital, Barcelona

All Listed Sponsors
lead

Corindus Inc.

INDUSTRY

NCT04236856 - CorPath® GRX Neuro Study | Biotech Hunter | Biotech Hunter